Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Different types of stem cells in the skin contribute to the variety of melanoma forms.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.